References
- Anderson HR. Prevalence of asthma. Brit Med J 2005;330:1037-8
- Antonicelli L, Bucca C, Neri M, et al. Asthma severity and medical resource utilisation. Eur Respir J 2004;23:723-9
- Arnlind MH, Nokela M, Rehnberg C, et al. The relationship between pharmaceutical costs, disease severity, and health-related quality of life in asthmatics in Swedish primary care. J Asthma 2006;43:585-91
- Jansson S-A, Ronmark E, Forsberg B, et al. The economic consequences of asthma among adults in Sweden. Respir Med 2007;101:2263-70
- Keller MB, Lowenstein SR. Epidemiology of asthma. Semin Respir Crit Care Med 2002;23:317-29
- Rabe KF, Adachi M, Lai CKW, et al. Worldwide severity and control of asthma in children and adults: The global Asthma Insights and Reality surveys. J Allergy Clin Immun 2004;114:40-7
- Rabe KF, Vermeire PA, Soriano JB, et al. Clinical management of asthma in 1999: the Asthma Insights and Reality in Europe (AIRE) study. Eur Respir J 2000;16:802-7
- Vermeire PA, Rabe KF, Soriano JB, et al. Asthma control and differences in management practices across seven European countries. Respir Med 2002;96:142-9
- Global Initiative for Asthma (GINA). The Global Strategy for Asthma Management and Prevention, 2007. Available at: http://www.ginaasthma.org/Guidelines/Guidelines-resources.html [Last accessed 2011]
- Chinn S, Jarvis D, Burney P, et al. Increase in diagnosed asthma but not in symptoms in the European Community Respiratory Health Survey. Thorax 2004;59:646-51
- Hermann-Kunz E, Allergic diseases in Germany. Bundesgesundheitsbl – Gesundheitsforsch – Gesundheitsschutz 2000;43:400-6
- Beasley R. Unmet need in inadequately controlled asthma. Respirology 2007;12:S18-S21
- Gaga M, Papageorgioou N, Karydi P, et al. Risk factors and characteristics associated with severe and difficult to treat asthma phenotype: an analysis of the ENFUMOSA group of patients based on the ECRHS questionnaire. Clin Exp Allergy 2005;35:954-9
- Barnes PJ, Woolcock AJ. Difficult asthma. Eur Respir J 1998;12:1209-18
- Busse WW, Banks-Schlegel S, Wenzel S. Pathophysiology of severe asthma. J Allergy Clin Immunol 2000;106:1033-42
- Buhl R, Berdel D, Criee C, et al. Guidelines for diagnosis and treatment of asthma patients. German Airway League and German Respiratory Society. Pneumonologie 2006;60:139-83
- Gibson PG, Simpson JL. The European Network For Understanding Mechanisms Of Severe Asthma study. Eur Respir J 2004;23:492-5
- Niven R, Chung KF, Panahloo Z, et al. Effectiveness of omalizumab in patients with inadequately controlled severe persistent allergic asthma: an open-label study. Respir Med 2008;102:1371-8
- Bateman ED, Boushey HA, Bousquet J, et al. Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma ControL Study. Am J Respir Crit Care 2004;170:836-44
- Busse WW, Wolfe J, Storms W, et al. Fluticasone propionate compared with zafirkulast in controlling persistent asthma: a randomized double-blind, placebo-controlled trial. J Fam Pract 2001;50:595-602
- Nathan RA, Bleecker E, Kalberg C. A comparison of short-term treatment with inhaled fluticasone proprionate and zafirkulast for patients with persistent asthma. Am J Med 2001;111:195-202
- Wittchen HU, Kardos P, Mühlig S, et al. The prevalence of severe allergic asthma in routine care – results from a nationwide epidemiological study. MMW submitted
- Wittchen HU, Mühlig S, Klotsche J, et al. Omalizumab vs. a matched ‘treatment as usual’ control group in routine care: a naturalistic 6–8 months follow-up of 106 patients with allergic asthma. Int Arch Allergy Immunol, submitted
- Bundesärztekammer (BÄK). Kassenärztliche Bundesvereinigung (KBV), Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF), Nationale Versorgungsleitlinie Asthma, 2nd Edn, 2009
- Klotsche J, Leistner D, Pieper L, et al. The DETECT Adherence Score – structure and psychometric exploration of a novel approach to measure adherence to drug and non-drug interventions in primary care. Int J Method Psych 2011;20:82-92
- Schatz M, Sorkness CA, Li JT, et al. Asthma Control Test: reliability, validity, and responsiveness in patients not previously followed by asthma specialists. J Allergy Clin Immunol 2006;117:549-56
- Ritz T, Steptoe A, Bobb C, et al. The asthma trigger inventory: validation of a questionnaire for perceived triggers of asthma. Psychosom Med 2006;68:956-65
- Juniper EF, Guyatt GH, Epstein RS, et al. Evaluation of impairment in health related quality-of-life in asthma – development of a questionnaire for use in clinical-trials. Thorax 1992;47:76-83
- Greiner W, Weijnen T, Nieuvenhuizen M, et al. A European EQ-5D VAS valuation set. In: Brooks R, Rabin R, de Charro F (eds). The Measurement and Valuation of Health Status Using EQ-5D – A European Perspective. Dortrecht: Kluwer, 2003:103-42
- Wittchen H-U, Kessler RC, Üstün TB. Properties of the Composite International Diagnostic Interview (CIDI) for measuring mental health outcome. In: Tansella M, Thornicroft G (eds). Mental Health Outcome Measures. London: Gaskell, 2001:212-27
- Wittchen H-U, Glaesmer H, März W, et al. Cardiovascular risk factors in primary care patients: methods and baseline prevalence. Results from the DETECT Program. Curr Med Res Opin 2005;21:619-29
- Royall RM. Model robust confidence intervals using maximum likelihood estimators. Int Stat Rev 1986;54:221-26
- Brown SB, Vigil L, Khan DA, et al. A randomized trial of citalopram versus placebo in outpatients with asthma and major depressive disorder: a proof of concept study. Biol Psychiat 2005;58:865-70
- Juniper EF, Guyatt GH, Willan A, et al. Determining a minimal important change in a disease specific quality-of-life questionnaire. J Clin Epidemiol 1994;47:81-7
- Greenblatt M, Galpin JS, Hill C, et al. Comparison of doctor and patient assessments of asthma control. Respir Med 2010;104:356-61
- Kendrick AH, Higgins CM, Whitfield MJ, et al. Accuracy of perception of severity of asthma: patients treated in general practice. Br Med J 1993;307:422-4
- Priel B, Heimer D, Rabinowitz B, et al. Perceptions of asthma severity: the role of negative affectivity. J Asthma 1994;31:479-84
- Dahme B, Richter R, Maß R. Interoception of respiratory resistance in asthmatic patients. Biol Psychology 1996;42:215-29
- Massasso DH, Salome CM, King GG, et al. Perception of bronchodilatation in subjects with asthma and smokers with airflow limitation. Respirology 1999;4:117-24
- Magadle R, Berar-Yanay N, Weiner P. The risk of hospitalization and near fatal and fatal asthma in relation to the perception of dyspnea. Chest 2002;121:329-33
- Bogaerts K, Notebaert K, van Diest I, et al. Accuracy of symptom perception in different affective contexts. J Psychosom Res 2005;58:537-43
- Rietveld S, Van Beest, I. Prins PJM. The relationship between specific anxiety syndromes and somatic symptoms in adolescents with asthma and other chronic diseases. J Asthma 2005;42:725-30
- Yawn BP, Molen T, Humbert M. Asthma management: are GINA guidelines appropriate for daily clinical practice? Prim Care Respir J 2005;14:294-302
- Katon W, Lozano P, Russo J, et al. The prevalence of DSM-IV anxiety and depressive disorders in youth with asthma compared with controls. J Adolescent Health 2007;41:455-63
- Kullowatz A, Kanniess F, Dahme B, et al. Association of depression and anxiety with health care use and quality of life in asthma patients. Respir Med 2007;101:638-44
- Oga T, Nishimura K, Sato S. Analysis of longitudinal changes in the psychological status of patients with asthma. Respir Med 2007;101:2133-8
- DiMatteo MR, Giordani PJ, Lepper HS, et al. Patient adherence and medical treatment outcomes – a meta-analysis. Med Care 2002;40:794-811
- Bousquet J, Boulet LP, Peters MJ, et al. Budesonide/formoterol for maintenance and relief in uncontrolled asthma vs. high-dose salmeterol/fluticasone. Respir Med 2007;101:2437-46
- Mawhinney H, Spector S, Kinsman A, et al. Compliance in clinical trials of two nonbronchodilator, anti-asthma medications. Ann Allergy 1991;66:294-9
- Rand CS, Wise RA, Nides M, et al. Metered-dose inhaler adherence in a clinical trial. Am Rev Respir Dis 1992;146:1559-64
- Corsico AG, Cazzoletti L, de Marco R, et al. Factors affecting adherence to asthma treatment in an international cohort of young and middle-aged adults. Respir Med 2007;101:1363-7